Heme oxygenase-1 protects against Alzheimer's amyloid-β1-42-induced toxicity via carbon monoxide production

Cell Death and Disease

Volumn 5, Issue 12, 2014, Pages

  Hettiarachchi, N T ^a   Dallas, M L ^a,b   Al Owais, M M ^a   Griffiths, H H ^a,c   Hooper, N M ^a,c   Scragg, J L ^a   Boyle, J P ^a   Peers, C ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CARBON MONOXIDE; HEME OXYGENASE 1; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; WHOLE CELL PATCH CLAMP; ANIMAL; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; ENZYMOLOGY; GENETICS; HIPPOCAMPUS; METABOLISM; MOUSE; NERVE CELL; PATHOPHYSIOLOGY; WISTAR RAT;

RATTUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; CARBON MONOXIDE; CELL SURVIVAL; CELLS, CULTURED; HEME OXYGENASE-1; HIPPOCAMPUS; HUMANS; MICE; NEURONS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 84927933879     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.529     Document Type: Article

References (61)

1. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002; 298: 789-791.
2. Coleman PD, Yao PJ. Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 2003; 24: 1023-1027.
3. Conforti L, Adalbert R, Coleman MP. Neuronal death: where does the end begin? Trends Neurosci 2007; 30: 159-166.
4. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2006; 103: 5161-5166.
5. Culmsee C, Mattson MP. p53 in neuronal apoptosis. Biochem Biophys Res Commun 2005; 331: 761-777.
6. LeBlanc AC. The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death. Curr Alzheimer Res 2005; 2: 389-402.
7. Bredesen DE, Rao RV, Mehlen P. Cell death in the nervous system. Nature 2006; 443: 796-802.
8. Culmsee C, Landshamer S. Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders. Curr Alzheimer Res 2006; 3: 269-283.
9. Mehta SL, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 2007; 54: 34-66.
10. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 1996; 46: 154-159.
11. Desmond DW, Moroney JT, Sano M, Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 2002; 33: 2254-2260.
12. Peers C, Pearson HA, Boyle JP. Hypoxia and Alzheimer's disease. Essays in Biochemistry 2007; 43: 153-164.
13. Yu SP, Canzoniero LM, Choi DW. Ion homeostasis and apoptosis. Curr Opin Cell Biol 2001; 13: 405-411.
14. Yu SP, Choi DW. Ions, cell volume, and apoptosis. Proc Natl Acad Sci USA 2000; 97: 9360-9362.
15. Bortner CD, Hughes FM Jr, Cidlowski JA. A primary role for K+ and Na+ efflux in the activation of apoptosis. J Biol Chem 1997; 272: 32436-32442.
16. Hughes FM Jr, Bortner CD, Purdy GD, Cidlowski JA. Intracellular K+ suppresses the activation of apoptosis in lymphocytes. J Biol Chem 1997; 272: 30567-30576.
17. Bortner CD, Cidlowski JA. Cellular mechanisms for the repression of apoptosis. Annu Rev Pharmacol Toxicol 2002; 42: 259-281.
18. Yu SP. Regulation and critical role of potassium homeostasis in apoptosis. Prog Neurobiol 2003; 70: 363-386.
19. Yu SP, Yeh CH, Sensi SL, Gwag BJ, Canzoniero LM, Farhangrazi ZS et al. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 1997; 278: 114-117.
20. Aizenman E, Stout AK, Hartnett KA, Dineley KE, McLaughlin B, Reynolds IJ. Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J Neurochem 2000; 75: 1878-1888.
21. Bossy-Wetzel E, Talantova MV, Lee WD, Scholzke MN, Harrop A, Mathews E et al. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 2004; 41: 351-365.
22. Pal S, Hartnett KA, Nerbonne JM, Levitan ES, Aizenman E. Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels. J Neurosci 2003; 23: 4798-4802.
23. Dallas ML, Boyle JP, Milligan CJ, Sayer R, Kerrigan TL, McKinstry C et al. Carbon monoxide protects against oxidant-induced apoptosis via inhibition of Kv2.1. FASEB J 2011; 25: 1519-1530.
24. Pal SK, Takimoto K, Aizenman E, Levitan ES. Apoptotic surface delivery of K+ channels. Cell Death Differ 2006; 13: 661-667.
25. Thornton C, Bright NJ, Sastre M, Muckett PJ, Carling D. AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid beta-peptide exposure. Biochem J 2011; 434: 503-512.
26. Yoon SO, Park DJ, Ryu JC, Ozer HG, Tep C, Shin YJ et al. JNK3 perpetuates metabolic stress induced by Abeta peptides. Neuron 2012; 75: 824-837.
27. Schipper HM. Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med 2004; 37: 1995-2011.
28. Kim HP, Ryter SW, Choi AM. CO as a cellular signaling molecule. Annu Rev Pharmacol Toxicol 2006; 46: 411-449.
29. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86: 583-650.
30. Wu L, Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 2005; 57: 585-630.
31. Dennery PA. Regulation and role of heme oxygenase in oxidative injury. Curr Top Cell Regul 2000; 36: 181-199.
32. Dwyer BE, Nishimura RN, Lu SY. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res Mol Brain Res 1995; 30: 37-47.
33. Pappolla MA, Chyan YJ, Omar RA, Hsiao K, Perry G, Smith MA et al. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol 1998; 152: 871-877.
34. Schipper HM, Cisse S, Stopa EG. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 1995; 37: 758-768.
35. Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, Kelly J et al. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 2006; 27: 252-261.
36. Zeynalov E, Dore S. Low doses of carbon monoxide protect against experimental focal brain ischemia. Neurotox Res 2009; 15: 133-137.
37. Al-Owais MM, Scragg JL, Dallas ML, Boycott HE, Warburton P, Chakrabarty A et al. Carbon monoxide mediates the anti-apoptotic effects of heme oxygenase-1 in medulloblastoma DAOY cells via K+ channel inhibition. J Biol Chem 2012; 287: 24754-24764.
38. Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457: 1128-1132.
39. Rushworth JV, Griffiths HH, Watt NT, Hooper NM. Prion protein-mediated toxicity of amyloid-beta oligomers requires lipid rafts and the transmembrane LRP1. J Biol Chem 2013; 288: 8935-8951.
40. Nicoll AJ, Panico S, Freir DB, Wright D, Terry C, Risse E et al. Amyloid-beta nanotubes are associated with prion protein-dependent synaptotoxicity. Nat Commun 2013; 4: 2416.
41. Murphy BJ, Laderoute KR, Short SM, Sutherland RM. The identification of heme oxygenase as a major hypoxic stress protein in Chinese hamster ovary cells. Br J Cancer 1991; 64: 69-73.
42. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997; 272: 5375-5381.
43. Kinobe RT, Dercho RA, Nakatsu K. Inhibitors of the heme oxygenase-carbon monoxide system: on the doorstep of the clinic? Can J Physiol Pharmacol 2008; 86: 577-599.
44. Redman PT, He K, Hartnett KA, Jefferson BS, Hu L, Rosenberg PA et al. Apoptotic surge of potassium currents is mediated by p38 phosphorylation of Kv2.1. Proc Natl Acad Sci USA 2007; 104: 3568-3573.
45. Chen K, Gunter K, Maines MD. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem 2000; 75: 304-313.
46. Song W, Zukor H, Lin SH, Liberman A, Tavitian A, Mui J et al. Unregulated brain iron deposition in transgenic mice over-expressing HMOX1 in the astrocytic compartment. J Neurochem 2012; 123: 325-336.
47. Schipper HM, Song W, Zukor H, Hascalovici JR, Zeligman D. Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem 2009; 110: 469-485.
48. Schipper HM, Gupta A, Szarek WA. Suppression of glial HO-1 activity as a potential neurotherapeutic intervention in AD. Curr Alzheimer Res 2009; 6: 424-430.
49. Imuta N, Hori O, Kitao Y, Tabata Y, Yoshimoto T, Matsuyama T et al. Hypoxia-mediated induction of heme oxygenase type I and carbon monoxide release from astrocytes protects nearby cerebral neurons from hypoxia-mediated apoptosis. Antioxid Redox Signal 2007; 9: 543-552.
50. Perera WS, Hooper NM. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region. Curr Biol 2001; 11: 519-523.
51. Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A et al. Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 2012; 15: 1227-1235.
52. Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Muller V, Krishnan R et al. The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO J 2011; 30: 2057-2070.
53. Chen S, Yadav SP, Surewicz WK. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. J Biol Chem 2010; 285: 26377-26383.
54. Correia SC, Moreira PI. Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration? J Neurochem 2010; 112: 1-12.
55. Yu SP, Farhangrazi ZS, Ying HS, Yeh CH, Choi DW. Enhancement of outward potassium current may participate in beta-amyloid peptide-induced cortical neuronal death. Neurobiol Dis 1998; 5: 81-88.
56. Colom LV, Diaz ME, Beers DR, Neely A, Xie WJ, Appel SH. Role of potassium channels in amyloid-induced cell death. J Neurochem 1998; 70: 1925-1934.
57. Mercer RC, Ma L, Watts JC, Strome R, Wohlgemuth S, Yang J et al. The prion protein modulates A-type K+ currents mediated by Kv4.2 complexes through dipeptidyl aminopeptidase-like protein 6. J Biol Chem 2013; 288: 37241-37255.
58. Goodison WV, Frisardi V, Kehoe PG. Calcium channel blockers and Alzheimer's disease: potential relevance in treatment strategies of metabolic syndrome. J Alzheimers Dis 2012; 30: S269-S282.
59. Mairet-Coello G, Courchet J, Pieraut S, Courchet V, Maximov A, Polleux F. The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Abeta Oligomers through Tau Phosphorylation. Neuron 2013; 78: 94-108.
60. Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 2010; 9: 728-743.
61. Watt NT, Taylor DR, Kerrigan TL, Griffiths HH, Rushworth JV, Whitehouse IJ et al. Prion protein facilitates uptake of zinc into neuronal cells. Nat Commun 2012; 3: 1134.